Pricing Log in Create free account
Friday 6 November 2026 Export BKD’s income statement to Excel — free account

Brookdale Senior Living Inc.

BKD Healthcare Medical Care Facilities

Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024.

Revenue
−11.6%
EPS
+155.6%
Free cash flow
+533.1%
Total debt
+0.07%

Quarter to June 2026, against a year earlier

10.89 0.30 −2.68%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
341×
Dividend yield
—
F-score
5/9
Altman Z
−0.22
Beneish M
−2.63
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 6.90%

Capital & Financial Ratios $m

Size
Market Cap 2,580.00
Revenue ttm 3,050.70
Net income ttm (138.36)
Free cash flow ttm (140.98)
Net debt Q 3,895.85
Valuation
P/E 0.00
Forward P/E 341.00 (above 35: high)
Price / sales 0.85
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.00
Financial health
Current ratio Q 1.14
Debt / equity Q (156.38) (negative: negative equity)
Interest coverage Q 1.51
Growth
Revenue growth Q −11.61% (below 0%: shrinking)
Operating income growth Q +471.87% (above 0%: growing)
EPS, this year +102.68% (at or above 15%: strong)
EPS, next year A +477.78% (at or above 15%: strong)
Revenue, next year A −8.64% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +45.59% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.1×, against a ten-year median of 1.6×; over the ten years it ranged from 1.1× in 2020 to 2.5× in 2026.
P/S against its own 10 years 93.47%
10-year low 10-year high
EV/Sales against its own 10 years 93.47%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 349 369 312 424
Receivables 48 52 68 56
Inventory — — — —
Other — — 77 24
478 513 554 597
2023 2024 2025 Q'26
Payables 67 66 75 83
ST’ Debt 41 41 77 71
Other 56 61 66 60
600 580 568 522

Compound Annual Growth %

10y 5y 3y
Sales (4.31%) (2.04%) 4.17%
Cash Flow (2.89%) 1.18% 305.05%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate −0.04 Actual 0.10

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 −0.16 −0.20 Miss by 0.04
Q4 FY25 −0.16 −0.17 Miss by 0.01
Q1 FY26 0.03 0.00 Miss by 0.03
Q2 FY26 −0.04 0.10 Beat by 0.14
Q3 FY26 −0.02 — Reports 6 November 2026

EPS $

Mar Jun Sep Dec Year
’26 (0.03) 0.10 — — —
’25 (0.28) (0.18) (0.48) (0.17) (1.12)
’24 (0.13) (0.17) (0.22) (0.37) (0.89)
’23 (0.20) (0.02) (0.22) (0.40) (0.84)
’22 (0.54) (0.45) (0.15) (0.13) (1.25)
’21 (0.59) (0.45) 0.89 (0.44) (0.54)
’20 2.00 (0.65) (0.68) (0.24) 0.44
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 765 719 — — —
’25 814 813 813 754 3,194
’24 783 778 784 781 3,125
’23 753 751 757 754 3,016
’22 678 690 757 701 2,825
’21 749 723 642 644 2,758
’20 1,014 866 808 852 3,540
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 21 92 — — —
’25 23 84 77 35 218
’24 (1) 56 66 45 166
’23 24 64 46 29 163
’22 (23) 12 64 (49) 3
’21 (24) 3 7 (81) (95)
’20 57 152 (77) 73 206
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (26) 191 — — —
’25 (18) 30 34 (340) (295)
’24 (45) 3 11 (114) (143)
’23 (26) 3 24 (72) (71)
’22 (63) (45) 10 (95) (194)
’21 (64) (36) (39) (132) (271)
’20 (12) (338) (131) 501 20
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 4,977 4,747 4,531 4,057 3,540 2,758 2,825 3,016 3,125 3,194 3,051 (4.8%) 2,918 2,994 3,165 (0.3%)
Gross margin, % 43.75 45.18 45.86 41.08 33.85 24.74 26.25 29.38 30.15 30.62 30.78 (13.1) pt
EBT (399) (588) (578) (271) 87 (108) (240) (180) (197) (265) (134) (4.5%)
EBT margin, % (8.02) (12.39) (12.75) (6.67) 2.47 (3.90) (8.49) (5.98) (6.31) (8.29) (4.40) (0.3) pt
Net income (405) (572) (528) (268) 82 (99) (238) (189) (202) (263) (138) (4.7%)
Per share, $
Per share, $ Revenue 26.81 25.50 24.17 21.82 19.29 14.91 14.83 13.39 13.74 13.58 12.76 (7.3%)
Earnings (2.18) (3.07) (2.82) (1.44) 0.45 (0.54) (1.25) (0.84) (0.89) (1.12) (0.58) (7.1%)
Cash flow 2.01 2.03 1.09 1.16 1.12 (0.51) 0.02 0.72 0.73 0.93 0.94 (8.3%)
Capex (1.80) (1.15) (1.20) (1.64) (1.01) (0.95) (1.03) (1.04) (1.36) (2.18) (1.53) +2.2%
Free cash flow 0.22 0.88 (0.11) (0.47) 0.11 (1.47) (1.02) (0.31) (0.63) (1.25) (0.59) n/m
Book value 11.19 8.22 5.43 3.76 4.37 3.78 3.07 1.80 0.94 (0.18) (0.12) n/m
Shares, m 186 186 187 186 183 185 190 225 228 235 237 +2.7%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 10.07 0.00 0.00 0.00 0.00 0.00 0.00 1.0
P/S 0.48 0.40 0.28 0.33 0.23 0.35 0.19 0.43 0.37 0.79 0.85 0.4
P/B 1.14 1.24 1.23 1.93 1.01 1.36 0.90 3.18 5.35 0.00 0.00 1.7
EV/Sales 1.63 1.34 1.17 1.32 1.33 1.73 1.46 1.59 1.63 2.05 2.13 1.5
EV/FCF (45.55) 38.78 (246.69) (60.59) 237.20 (17.59) (21.29) (67.56) (35.58) (22.21) (46.10) (24.1)
Cash, $m
Cash, $m Operating cash flow 374 378 204 216 206 (95) 3 163 166 218 224 (5.8%)
Capex (334) (214) (225) (305) (186) (177) (197) (234) (310) (513) (365) +4.9%
Free cash flow 40 164 (22) (88) 20 (271) (194) (71) (143) (295) (141) n/m
Balance, $m
Balance, $m Working capital (112) (194) 1 (451) 83 67 (4) (122) (67) (14) 75 (20.6%)
Net debt 5,726 4,484 4,051 3,991 3,878 3,817 3,600 3,499 3,961 4,005 3,896 (3.9%)
Shareholders’ equity 2,078 1,530 1,018 699 803 700 584 405 214 (43) (28) n/m
Returns, %
Returns, % ROA (4.20) (6.77) (7.47) (3.92) 1.16 (1.49) (3.86) (3.28) (3.39) (4.28) (2.30) (0.1) pt
ROIC (0.25) (2.81) (7.33) (0.59) (1.30) (3.00) (0.64) 0.29 0.70 0.21 1.71 +0.5 pt
ROE (17.83) (31.67) (41.45) (31.21) 10.93 (13.22) (37.14) (38.21) (65.24) (308.09) (349.46) (290.3) pt
People
People Employees 77,600 75,600 65,400 58,400 — — — — — — — (9.0%)
Revenue/emp, $m 0.06 0.06 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Brookdale Senior Living Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NHC National HealthCare Corporation $3.3B 28.2× 8.4× +6.61% (above 0%: growing) −65.61% (below 0%: shrinking) +75.52% (above 0%: growing) 100.00% 0.00% Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00% Compare
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
BKD Brookdale Senior Living Inc. $2.6B — (loss-making) 341× −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86%
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.8× 33.3× −1.68% (below 0%: shrinking) +133.33% (above 0%: growing) +88.88% (above 0%: growing) 22.97% 6.75% Compare
MD Pediatrix Medical Group, Inc. $2.5B 17.1× 15.3× +1.72% (above 0%: growing) −27.61% (below 0%: shrinking) −14.41% (below 0%: shrinking) 27.98% 13.01% Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27% Compare
ASTH Astrana Health, Inc. $1.9B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
Median of peers $2.8B 24.6× 20.3× +5.88% +24.19% +21.74% 30.03% 8.51%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 30 April 2026

Ownership

Directors and executive officers, together less than 1%
The Vanguard Group 7.60%
BlackRock, Inc. 6.10%
WCM Investment Management LLC 5.40%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Brookdale Senior Living Inc. (BKD) Latest News

29 Oct

Impact 3 · · Insider Monkey

27 Oct

Impact 3 · · Insider Monkey

26 Oct

Impact 3 · · StockStory

23 Oct

Impact 3 · · PR Newswire

14 Oct

Impact 4 · · bisnow.com

13 Oct

Impact 4 · · PR Newswire

10 Oct

Impact 4 · · Simply Wall St.

9 Oct

Impact 3 · · MT Newswires

8 Oct

Impact 3 · · PR Newswire

7 Oct

Impact 3 · · Zacks

6 Oct

Impact 3 · · StockStory

20 Aug

Impact 3 ·

17 Aug

Impact 3 · · The Motley Fool transcript
Impact 3 ·

11 Aug

Impact 4 ·
Impact 3 · transcript
Impact 3 · · MarketBeat transcript
Impact 3 · · Moby

10 Aug

Impact 3 ·

5 Aug

Impact 4 ·

21 Jul

Impact 3 ·

10 Jul

Impact 3 ·

7 Jul

Impact 3 ·

6 Jul

Impact 3 ·

2 Jul

Impact 3 ·

12 Jun

Impact 3 ·

10 Jun

Impact 3 · · Insider Monkey

9 Jun

Impact 3 · · Zacks
Impact 3 · · MT Newswires

16 May

Impact 3 · · StockStory

BKD metrics, ten years each

stockrow.com/BKD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com